The comprehensive medical preparedness in chemical emergencies: 'The chain of chemical survival'

European Journal of Emergency Medicine

Volumn 15, Issue 2, 2008, Pages 110-118

  Barelli, Alessandro ^a   Biondi, Immacolata ^a   Soave, Maurizio ^a   Tafani, Chiara ^a   Bononi, Francesca ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antidote stockpiling; Chemical hazard; Decontamination; Personal protection equipment; Supportive care

Indexed keywords

AMITON; ANTIDOTE; CHLORMETHINE; CHLOROPICRIN; ENVIRONMENTAL POISON; EXPLOSIVE; HYDROGEN CYANIDE; IRRITANT AGENT; LEWISITE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; MUSTARD GAS; OXIDIZING AGENT; PHOSGENE; QUINUCLIDINYL BENZILATE; RICIN; SARIN; SAXITOXIN; SOMAN; TABUN;

BOTULISM; BREATHING APPARATUS; CHEMICAL TERATOGENESIS; CHEMICAL WARFARE; CORROSION; DANGEROUS GOODS; DESTRUCTION; EMERGENCY; EYE IRRITATION; GERM CELL; HEALTH HAZARD; HUMAN; INTOXICATION; MUTAGENICITY; PRIORITY JOURNAL; PROTECTIVE CLOTHING; PROTECTIVE EQUIPMENT; REPRODUCTIVE TOXICITY; REVIEW; SKIN IRRITATION; SKIN PROTECTION; SURVIVAL; TERRORISM; VENTILATOR; WASTE MANAGEMENT; DISASTER PLANNING; EMERGENCY HEALTH SERVICE; EMERGENCY TREATMENT; ITALY; ORGANIZATION AND MANAGEMENT; SAFETY;

ANTIDOTES; CHEMICAL TERRORISM; DECONTAMINATION; DISASTER PLANNING; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; HAZARDOUS SUBSTANCES; HUMANS; ITALY; SAFETY MANAGEMENT;

EID: 45549108139     PISSN: 09699546     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEJ.0b013e3280bef902     Document Type: Review

References (49)

1. Kuca K, Cabal J, Kassa J, Jun D, Hrabinova M. A comparison of the potency of the oxime HLo-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. Acta Medica (Hradec Kralove) 2005; 48 :81-86.
2. The OSHA Hazard Communication Standard (HCS). Subpart Z: toxic and hazardous substances. Available at: http://www.ilpi.com/msds/osha.
3. United Nations Economic Commission for Europe. The globally harmonized system of classification and labeling for chemicals. Available at: http://www.unece.org.
4. North Atlantic Treaty Organisation. Handbook on the medical aspects of NBC defensive operations . Brussels: NATO; 1996.
5. Organization for the prohibition of chemical weapons. Convention on the prohibition of the development, production, stockpiling and use of chemical weapons and on their destruction. Available at: http://www.opcw.org/index.html.
6. Organization for the prohibition of chemical weapons. Guidelines for schedules of chemicals. Available at: http://www.opcw.org/index.html.
7. The Science Coalition. Glossary of scientific terms (2003). Available at: http://www.sciencecoalition.org/glossary/glossary-main.html.
8. Centres for Disease Controls and Prevention. Agents, diseases and other treats: chemical emergencies. Available at: http://www.bt.cdc.gov/agent/ agentlistchem-category.asp.
9. Cherrie JW. Selecting an adequate respiratory protective device: the choice between a respirator and breathing apparatus. Ann Occup Hyg 1998; 42 :91-95.
10. Committee on R&N needs for improving civilian medical response to chemical and biological terrorism incidents. Access to PPE. In: Institute of Medicine, editor. Chemical and biological terrorism; research and development to improve civilian medical response . Washington, DC: National Academy Press; 1999. pp. 35-36.
11. US Army. Protective measures and handling of casualties. In: Treatment of chemical agents casualties and conventional military chemical injuries . Washington, DC: US Government Printing Office; 1990. pp. 160-161.
12. Centers for Disease Control and Prevention. CDC recommendations for civilian communities near chemical weapons depots. Fed Regist 1995; 60 :33308-33312.
13. Sullivan J, Krieger G. Hazardous materials toxicology . Baltimore, Maryland: Williams & Wilkins; 1992.
14. Shapira Y, Bar Y, Berkenstadt H, Atsmon J, Danon Y. Outline of hospital organization for a chemical warfare attack. Isr J Med Sci 1991; 27 : 616-622.
15. Arnold JL, Lavonas E. CBRNE-Personal Protective Equipment. eMedicine Journal 2001; 2 (10). Available at: http://www.emedicine.com/EMERG/topic894.htm.
16. Organisation for Economic Co-operation and Development. OECD countries warn of continuing shortfalls in insurance coverage against terrorism. Available at: http://www.oecd.org/document.
17. Pedigo LG. Antagonism between amylnitrite and prussic acid. Tr M Soc Virg 1888; l9 :124-131.
18. Chen K, Rose CL, Clowes CA. Comparative values of several antidotes in cyanide poisoning. Amer J Med Sci 1954; 188 :767-781.
19. Graham DL, Laman D, Theodore J, Robin ED. Acute cyanide poisoning complicated by lactic acidosis and pulmonary edema. Arch Int Med 1977; 137 :1051-1055.
20. Sauer SW, Keim ME. Hydroxocobalamin: improved public health readiness for cyanide disasters. Ann Emerg Med 2001; 37 :635-641.
21. Dawson RM. Reviews of oximes available for treatment of nerve agents poisoning. J Appl Toxicol 1994; 14 :317-331.
22. Koplovitz I, Stewart JR. A comparison of the efficacy of HI-6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit. Toxicol Lett 1994; 70 :269-279.
23. Koplovitz I, Gresham VC, Dochterman LW, Kaminskis A, Stewart JR. Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphodphonofluoridate (CMPF) poisoning in rhesus monkeys. Arch Toxicol 1992; 66 :622-628.
24. Clement JG. Toxicity of the combined nerve agents GB/GF in mice: efficacy of atropine and various oximes and antidotes. Arch Toxicol 1994; 68 :64-66.
25. Petroianu GA, Arafat K, Kuca K, Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon. J Appl Toxicol 2006; 26 :64-71.
26. Shih T,Whalley CE, Valdes JJ. A comparison from cholinergic effects of HI-6 and pralidoxime-2- chloride (2-PAM) in soman poisoning. Toxicol Lett 1991; 55 :131-147.
27. Inns RH, Leadbeater L. The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea-pig. J Pharm Pharmacol 1983; 35 :427-433.
28. Lallement G, Clarencon D, Brochier G, Baubichon D, Galonnier M, Blanchet G, et al . Efficacy of atropine/pralidoxime/diazepam or atropine/HI-6/prodiazepam in primates intoxicated by soman. Pharmocol Biochem Behav 1997; 56 :326-332.
29. Kassa J, Cabal J, Bajgar J, Szinicz L. The choice: HI-6, pralidoxime or obidoxime against nerve agents? Available at: http://www.asanltr.com/ASANews-97/ Antidot-Choice.html.
30. Aas P. Future considerations for the medical management of nerve agent intoxication. Prehospital Disaster Med 2003; 18 :208-216.
31. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile informations sheet for hydrazines. Available at: http://www.atsdr.cdc. gov/toxprofiles/tp100.html.
32. Toth B, Erickson J. Reversal of the toxicity of hydrazine an analogues by pyridoxine hydrochloride. Toxicology 1977; 7 :31-36.
33. Whitney GD,Wolfle TL, Batson PY. Behavior of primates following injection of monomethylhydrazine with and without pyridoxine. Aerosp Med 1968; 39 :1283-1286.
34. Holstege CP, Kirk M, Sidell FR. Chemical warfare: nerve agent poisoning. Crit Care Clin 1997; 13 :923-942.
35. Nozaki H, Hori S, Shinozawa Y. Secondary exposure of medical staff to sarin vapor in the emergency room. Intensive Care Med 1995; 21 : 1032-1035.
36. Sidell FR. Nerve agents. In: Zajtchuk R, Bellamy RF, editors. Textbook of military medicine (vol. 1) . Falls Church, Virginia: Office of the Surgeon General (Department of the Army); 1997. pp. 129-179.
37. De Jong RH. Chemical injury. In: Bowen TE, Bellamy RF, editors. NATO handbook of emergency war surgery . Washington, DC: Second United States Revision, US Department of Defence, 1988. pp. 83-94.
38. Gong E, Dauber W. Policewomen win settlement. Seattle Times 1996; Section B:1.
39. Stokes J, Banderet L. Psychological aspects of chemical defense and warfare. Mil Psychol 1997; 9 :395-415.
40. Sidell F. What to do in case of the unthinkable chemical warfare attack or accident. Postgrad Med 1990; 88 :70-84.
41. Adler J. Missile attacks on Israel during the Gulf War. Handout prepared for: National Disaster Medical System Conference on Lifesaving Intervention; May 4-7, 1997; Tampa, Flo. Available at: http://www.ndms.dhls.gov.
42. Walter FG, Klein R, Thomas GR, editors. Advanced Hazmat Life Support , 3rd ed . Tucson: American Academy of Clinical Toxicology and University of Arizona Emergency Research Center; 2003.
43. Nakajima T, Sato S. Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan. Occup Environ Med 1997; 54 :697-701.
44. Holstege CP, Kirk M, Sidell FR. Chemical warfare: nerve agent poisoning. Crit Care Clin 1997; 13 :923-942.
45. Abraham RB, Rudick V,Weinbroum AA. Practical guidelines for acute care of victims of bioterrorism: conventional injuries and concomitant nerve agent intoxication. Anesthesiology 2002; 97 :989-1004.
46. Quad-Service Field Manual. Nerve agents. In: Department of Defence, editors. Treatment of chemical agent casualties and conventional military chemical injuries . Washington, DC: Departments of the Army, Navy, and Air Force, and Commandant Marine Corps; 1995. pp 1-8.
47. Chemical Casualty Care Division (USAMRICD). Medical management of chemical casualties handbook . 3rd ed. Abingdon, Maryland: EAI Corp; 2000.
48. De Jong RH, Quebbeman HJ. Ventilation of the apneic chemical casualty. J US Army Med Department 1990; PB 8-90-6 :13-16.
49. Barelli A, Gargano F, Proietti R. In-hospital management of victims of chemical weapons of mass destruction. Ann Ist Super Sanita 2005; 41 :93-101.